AUSTIN -- Imagine struggling to breathe and getting worse every day. Four million Americans suffer from a condition called mitral valve regurgitation which causes blood to flow backward in the heart.

BOSTON, MA — Four-year follow-up of the Endovascular Valve Edge-to-Edge Repair Study II (EVEREST II) show no differences in the primary end point between the MitraClip (Abbott) procedure and surgery ...

Breakthrough MitraClip procedure repairs one heart structurally, another emotionally Date: July 10, 2014 Source: University of Alabama at Birmingham Summary: Mary York's heart broke when she heard her ...

Life became increasingly difficult for those patients who were facing chronic heart problems. Mitral valve leakage or regurgitation is the most common valvular heart disease. With a global prevalence ...

After four years, patients with Abbott's ($ABT) MitraClip cardiac device required additional operations, and the benefits of the device were no better than those of ...

The patient, identified as Hadi Mustafa Hamad, was suffering from unstable blood pressure and declining kidney function for ...

Allegheny General Hospital and UPMC Presbyterian Hospital are the first in the region to offer a minimally invasive heart surgery that allows physicians to operate as the heart beats. The MitraClip is ...

A 58-year-old Iraqi man, Hadi Mustafa Hamad, underwent a revolutionary heart procedure at Paras Health Gurugram, which ...

Long-axis view on TEE. PML = posterior mitral leaflet, AML = anterior mitral leaflet (Photo Credit: Hannes Alessandrini) As MitraClip procedures continue to expand as an option for nonsurgical ...

In symptomatic patients with severe mitral regurgitation (MR) at high surgical risk, transcatheter valve repair and surgery result in similarly high rates of survival, according to a study published ...

Mary Johnson is determined to live an independent, active lifestyle, even at the age of 85. She's a great-grandmother who doesn't like being told what she can and can't do. She likes to garden, ...

April 5, 2011 (New Orleans, Louisiana)-Results from the EVEREST IItrial out to two years show that percutaneous repair of the mitral valve with the MitraClip (Abbott) device was significantly less ...